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Abstract
Rationale, aims and objectives Although many believe that evidence-based practice
(EBP) has great potential, critics have identiﬁed limitations including a focus on random-
ized clinical trial (RCT) evidence to the exclusion of other evidence types and a disregard
for the art of medicine. Others have argued, however, that proper application of EBP
involves reasoned consideration of a wide variety of information; thus, the dichotomy
between medical science and art may be false. We explore the views of executive-level
policymakers from the Veterans Health Administration, a leader in the EBP movement,
regarding what constitutes evidence and the relative importance of evidence versus prac-
tical needs when determining clinical policy.
Method We conducted 26 semi-structured qualitative interviews and performed a content
analysis.
Results Although informants generally believed in the value of EBP and the role of RCTs
within it, they also valued other types of evidence. Further, they had concerns that were
sometimes antithetical with strict adherence to an evidence-based approach. These
included practical concerns, ﬁt with organizational values and with local circumstances,
resources, political pressures and patient needs. They were especially concerned about how
to address medical conditions that affect many individuals or high-risk populations that
have no evidence-based treatment.
Conclusion When possible, health care practice should be evidence-based. When this is
not possible, health care providers must turn to the art of medicine by using consensus-
based best practices. Further, it is important for policymakers and researchers to work in
concert to develop EBPs that are practical and meet needs.
Introduction
Historically, health care practitioners have considered their work
as much an art as a science, drawing upon clinical intuition honed
by years of experience [1]. Since the early 1990s, however, health
care practice based on scientiﬁc empirical evidence, known vari-
ously as evidence-based medicine, evidence-based health care, and
most generically, evidence-based practice (EBP), has taken the
health care industry by storm [2–4]. Although many health care
researchers, policymakers, and managers believe that basing
health care practices upon empirical evidence has great potential to
improve patient outcomes, critics have identiﬁed a number of
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evidence that EBP produces superior care and outcomes [6–8].
Much of the concern focuses on the assumption among many
EBP proponents that randomized clinical trials (RCTs), especially
double-blind trials, should provide the gold standard for clinical
evidence. Critics of this stance have argued that typical patients are
often more complicated and less compliant than those included in
RCTs [7,9–14]. Moreover, what we observe on average in groups
may not apply to a particular individual or context; by contrast, the
art of medicine accommodates individual patients’, providers’,
health care organizations’, communities’ and societies’ needs,
preferences and circumstances [4,7,12,14–17]. Additionally, as
RCTs’ focus is the effect of treatments on ﬁnal outcomes (e.g. the
number of patients who experience less of a particular symptom),
they do not explore the complex biological processes underlying
disease and health [15,18].
Interestingly, despite many EBP advocates’ claims that RCTs
provide the highest quality evidence, ﬁndings from observational
studies actually converge more often than do ﬁndings from RCTs
[6]. Further, health care evidence is a ‘fuzzy set’ in that there are
not always clear boundaries between what is and what is not
effective across studies [19]. Thus, it seems imprudent to assume
that one type of methodology provides the only path to knowledge.
We should note that many of the researchers and policy analysts
who are concerned about the centrality of RCT within the EBP
movement are not claiming that RCTs are valueless. Rather, these
critics propose that clinical decision makers should make reasoned
use of all available information, including qualitative and correla-
tion studies, providers’ clinical observations and context, patients’
experiences and context, as well as RCTs [3,8,16,20,21].
A number of health services researchers have observed that
qualitative methods (e.g. case studies, qualitative interviews and
qualitative observational studies) provide particularly viable
approaches for exploring the needs and preferences of health con-
sumers who do not ﬁt neatly into the types of groups RCTs require.
These include those with co-morbid conditions or complex life
circumstances [9,22,23,24]. Additionally, before researchers can
test treatments in an RCT, someone needs to discover them. Many
researchers reason that qualitative methods, such as case studies,
may play an important role in treatment discovery [6,15,16,25].
Qualitative methods are also valuable in discovering new diseases
and in describing disease mechanisms and treatment side effects
[18].
There are also quantitative methods other than RCT that can
provide valuable information regarding disease process, treatment,
and prevention. Although only experimental methods, such as
RCT, can establish causal relationships, quantitative correlational
methods are also valuable tools, especially where experiments
may be unethical. For example, physicians generally recommend
that patients do not smoke based on the well-established correla-
tion between smoking and lung disease rather than on any experi-
ment deﬁnitively demonstrating that smoking causes such disease.
Finally, Buetow and Kenealy proposed that EBP should include
not just research evidence, whether it is qualitative or quantitative,
but also theoretical, practical, experiential, expert, judicial and
ethical evidence [26].
Also of concern is the nature of research publication and
funding. As journal editors prefer to publish statistically signiﬁ-
cant positive results, reviews of the research literature may over
estimate true effect sizes. This issue, known as the ‘ﬁle draw’
problem or effect because negative ﬁndings do not enter the lit-
erature but rather literally languish in investigators’ ﬁle draws,
affects all sciences. Quite simply, it is far easier to learn of trials
where treatments do work than it is to learn of those where they do
not. Further, there is more research funding for commercially
viable interventions (e.g. proﬁtable pharmaceuticals) than for
interventions with limited commercial value (e.g. lifestyle and
dietary changes). Additionally, some treatments (e.g. pharmaceu-
ticals) are more amenable to EBP methods, such as double-blind
RCT, than others (e.g. lifestyle changes, psychotherapy and many
procedures). Thus, there may be more published evidence created
for certain types of treatments than for others, regardless of their
actual value [2,4,7,11]. Finally, EBPsits at the nexus of the current
conﬂict between a traditional perhaps idealized view of health care
in which practitioners provide the best care, regardless of circum-
stances and costs, and a ‘rationalized’ system of care [11].
On the other hand, numerous health services researchers and
policy analysts have argued that proper application of EBP does
not involve dogmatic adherence to RCT results alone. Rather, EBP
should include consideration of evidence from a wide variety of
sources, as well as individual patient and provider experiences and
local context [1,3,6,20,21,25,27,28]. As such, the dichotomy
between EBP and medical art may be false.
In this article, we explore the views of US Veterans Health
Administration (VHA) executive-level policymakers regarding the
relative importance of research evidence and of patient and other
needs when determining clinical policy. We also explore their
views on what they believe constitutes evidence. We believe the
VHAprovides a particularly important context for exploring these
issuesbecauseitisoneoftheworldleadersinthedevelopmentand
implementation of EBP. Most notably, the VHA established the
Quality Enhancement Research Initiative to foster the translation
of research evidence into clinical care [29]. Further, VHAmedical
centres are academically afﬁliated and medical schools have
largely embraced EBP [12].
Methods
Data collection
As part of a study concerned with understanding how to imple-
ment and sustain organization-wide clinical quality improvement
(QI) programmes, we identiﬁed a purposive sample of 28 current
and former executive-level VHA policymakers and key members
of their staff. Twenty-six of these agreed to participate in the study
and we were able to conduct 12 of these interviews face-to-face at
informants’ ofﬁces during two site visits to the VA Central Ofﬁce
in Washington, District of Columbia, USA. We interviewed 14
informants who were unavailable for face to face interviews or
who had ofﬁces in locations other than Washington via telephone.
Three highly experienced qualitative interviewers, a psycholo-
gist, a psychiatrist and a social worker, conducted all the inter-
views. Two of these three interviewers participated in each
interview with one serving as the lead interviewer and the other
serving as a back-up interviewer taking notes and ensuring that the
lead interviewer covered all crucial topics. The three interviewers
took turns serving in these capacities.
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structured protocol. Our protocol was semi-structured in that we
developed a topic list but we did not ask exactly worded questions
in an exact order and we did not have a closed response set.
Qualitative methods are useful when there is limited a priori
knowledge regarding the constructs of interest and the researchers
seek to discover new information rather than conﬁrm existing
hypotheses. Topic areas for this study included fostering partner-
ships betweenVHApolicymakers and researchers, integrating new
clinical programmes into the VHA structure, and the balance
between evidence and need in determining VHApolicy. The latter
topic is the focus of this article. We audio-recorded all interviews
and produced verbatim transcripts.
Data analysis
Utilizing Atlas.ti, a qualitative data management software
package, we conducted a content analysis of the verbatim tran-
scripts [30]. Speciﬁcally, we linked codes to passages within the
transcripts (i.e. quotations). Content analysis, one of the most
commonly used qualitative data analysis techniques, is similar to
creating a book index [31]. Data analysis for this study proceeded
over two phases.
First, two investigators reviewed the interview transcripts and
inductively developed top level codes that described major themes.
These included: (1) what convinces informants to support pro-
grammes; (2) how to integrate programmes into the VHA struc-
ture; (3) issues related to various VHAdepartments; (4) barriers to
researchers partnering with clinical managers and VHA central
ofﬁce policymakers; and (5) the balance between evidence and
clinical need in determining clinical policy. The two investigators
then each coded one half of the transcripts and reviewed 100% of
each other’s coding and resolved any differences.
Second, working in teams of two, investigators reviewed all
quotes linked to a particular top level code and inductively created
subcategories or sub-codes that described the content of the
quotes. Utilizing this sub-coding scheme, they each sub-coded one
half of the transcripts. Finally, they reviewed 100% of each other’s
coding and resolved any differences.
In this article, we focus on the sub-codes for the ‘balancing
evidence and need’top level code. Sub-codes concern: (1) value of
EBPin determining policy; (2) types of evidence valued; (3) limits
to EBP and the role of the art of medicine when addressing con-
cerns (e.g. ﬁtting with local clinic circumstances, ﬁtting with orga-
nizational and professional values, and meeting needs for which
there may or may not be evidence-based treatments); (4) types of
needs identiﬁed; (5) the ways in which clinical evidence may not
meet existing needs; (6) methods for meeting needs in the absence
of an applicable or complete evidence base; and (7) utilizing needs
to guide the direction of research so as to collect useful evidence.
Results
EBP and types of evidence valued
All else being equal, our informants generally believed that basing
clinical policy upon research evidence enhances quality. Many
believed that RCT provides the highest standard evidence:
Well, obviously I think the level one evidence [RCTs] is the
most compelling...[I]f they show us a research results that
are from random control trials, those speak volumes...
At the same time, they understood that RCTs were not always
viable:
A s...s o m e o n e...c o m m itted to the evidence-based psycho-
therapies...there’s some things you have to push against,
like the assumption that the gold standard is a randomized
controlled double-blind trial. Because, obviously, you can’t do
psycho-social research...blind.
Further, they also valued other types of evidence including
qualitative:
I want to see actually all of that [RCT, case studies, and testi-
monials]. And I value all of that. So I wouldn’t just want to
see it from just necessarily one approach. I don’t think that
addresses the whole issue.
[Case studies] play huge training roles...[R]eading the case
studies can give you more of a feel for what’s this like and
what’s the emotional experience of the patient, of the thera-
pist, you know, what are the choice points you reach and how
are those dealt with, how do you understand that approach to
therapy in a richer way.
I think that the other evidence that I’m always interested in is
[the new practices’] acceptability to the patient. And some of
those things are sort of embedded in research reports but are
perhaps not emphasized. So drop out rates, you know. Some-
times they’re just treated as a source of kind of error but I
think they’re pretty profoundly meaningful.
Beyond evidence: what else matters when
making clinical policy?
Practicality
As much as they valued evidence, however, informants also
believed there are other concerns when making policy decisions.
First, clinical programmes have to be practical:
[T]he practicality of it is a big part...h a si tbeen tested in a
typical environment or multiple typical environments...A n d
I wouldn’t say that we should always rely on...t h erigor of
the most pure science because then we would probably never
get done because it is usually so narrow that it’s hard to put
your arms around it and say that it applies to multiple settings
if it’s been tested in one setting...[S]ince we’re a provider
organization, a practice environment, it has to work in the
practice environment.
Fit with values and local circumstances and context
How well practices ﬁt with local clinical and individual values,
circumstances and context also factored into informants’ decision
making:
[T]he evidence is only one part of evidence-based
c a r e...other components...include understanding and
incorporating...v alues, hopefully the patient’s values, and
the context...[T]his fellow is left-handed and has red hair
and there’s no one in the clinical trials who’s left-handed and
has red hair. So is the context such that the evidence can be
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very fuzzy clinical judgment...[T]he values in Memphis
may be different than...v alues in Cleveland, and that should
affect what you do. And the context may be different as well
and to ﬁt between the hard evidence and the soft patient may
vary so much that it begs the case...Ithink there’s still more
to clinical care than applying evidence only.
Resources
Informants also believed it is important to consider organizational
resources:
There are great ideas that we could do and they could be very
expensive and in the end the beneﬁt is arguable, negligible.
I want to know that they’ve thought through the resources that
it would take...[T]oo many times, you know, people want to
do something, but they don’t think through that you’re adding
it on top of already busy people, and this is something that is
collateral duty now or is it something that’s going to replace
something else.
Political climate
Further, health care organizations, especially government funded
ones such asVHA, must be cognizant of the political climate when
making policies:
I think that we always remember where we work and who our
various bosses are. And we have the White House [U.S. Presi-
dent] three blocks from here and then those folks at the east
end of Pennsylvania Avenue [U.S. Congress]. And so a lot of
what we end up doing as a government agency is driven by
those particular dictates.
[W]hat’s priorities for the groups that support us, Congress,
[Veteran Service Organizations], et cetera. Sometimes you
get initiatives that...from our perspective may not be the
top impact clinically, but for other reasons...a r estrongly
being...recommended.
Patient need
Finally, informants considered the needs of patients paramount in
determining policy:
[I]f you go back to our vision statement for our system, it
reads, to be a patient-centered system ...Ithink all of these
things should be characterized as we’re pursuing this because
this is an intervention that is needed by our population or at
risk for these things.
I like to hear the volume of the patients that this will impact,
and I also want to know if this is a high-risk population,
because you can’t just go by volumes. Sometimes you need to
do it because it may be a small amount, but it’s a high-risk
population.
In the absence of evidence, use consensus and
work to build the evidence base
Given that informants believed that some needs are so compelling
that it is important to attempt to meet them even in the absence of
research evidence, it is necessary to identify other information to
assist with decision making. For most, clinical consensus was the
best approach in these instances:
[S]ometimes the highest level of evidence is consensus, and
you have to understand that that may be all you get...I fy o u
wait for level-one evidence for everything, you would do
hardly anything....T h eN C C N[ N ational Comprehensive
Cancer Network] guidelines for cancer, for example, they’ll
tell you right up front they’re consensus guidelines. But it
doesn’t mean you shouldn’t do it just because they’re consen-
sus guidelines. That’s the best thing we had, so that’s what
you use.
In such instances, however, informants would encourage propo-
nents to establish an evidence base:
If the public health need is serious and urgent enough, I will
go for less well-established evidence. But if I do that, then I
would push that somebody ought to be parallel with the
implementation actually work on establishing the evidence
base. In other words, I will use so called best-practices, so
often anecdotal but then I would say to the proponents that
you need to at least show me that you are working on this to
establish its effectiveness or efﬁcacy.
To further the goal of increasing the percentage of EBP, many of
our informants believed that clinical needs, rather than the interests
of academics, should guide research, at least in organizations with
clinical missions:
[W]e’re looking much more carefully at veteran centricity and
applicability of what we do across all the services...[ Y ]es,
we want to attract this wonderful investigator who does
basic science research [but]...I ft h e yw a n tt od oresearch,
they have it’s got to be much more hands on and veteran
centric.
Ultimately, however, the informants saw the need for balancing
the immediate needs of patients and the long-term scientiﬁc goals
when setting research agendas:
I think it has to be interactive and sometimes the process
should be driven by the needs of the programme or policy,
and sometimes it should be driven by the scientiﬁc opportuni-
ties that are ready for development. You know, I don’t speak
either/or...But, gee, you know, I’m just I think we have to
use the evidence as well as we can to meet the real needs. It
would be silly, I think, to do otherwise.
Finally, policymakers argued that following a particular line of
evidence blindly is unlikely to achieve sustainable QI. In other
words, to remain faithful to the spirit of the QI initiative, health
care organizations must listen and learn from the ﬁeld, as well as
the laboratory, and modify their practices accordingly:
So in essence, you know, the way to sustain is to actually
change. The way to maintain ﬁdelity is actually to change
what it means to be faithful...because I think some of the
things that may actually represent lack of faithfulness to
the intervention may actually be responses to needs that the
original model didn’t ﬁt...Ithink it’s very simplistic to
s a y...ﬁdelity means doing things just like in that trial. I
mean, you could pick apart anything...e v e nt h estudies that
have been done...[ V ]ery few studies actually get into the
level of the ingredients of the intervention and...w h a tinside
the black box is truly needed and how much of each of those
things...[ W ] e...k n o w...it’s nice to lower LDL choles-
L.E. Parker et al. Balancing clinical evidence and art
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lower LDL cholesterol and necessarily how we should lower
it.
Conclusions
It did not surprise us that these VHAexecutive-level policymakers
were strong proponents of EBP. As we mentioned earlier, VHA is
a leader in promoting EBPs. Further, and as we also indicated,
VHA’s nation-wide network of medical centres is afﬁliated with
medical schools and academic medicine has embraced EBP. Inter-
estingly, although these policymakers generally believed that
RCTs are valuable, they also believed that other forms of evidence,
including qualitative evidence, can be useful. Additionally, they
observed that it is not possible to conduct RCTs for certain types of
treatments.
The individuals that we interviewed, however, were also respon-
sible for developing policy for and administering a large public
health system. Thus, they had many concerns that were sometimes
in conﬂict with strict adherence to an evidence-based approach.
First, they believed that practices have to be practical in real world
clinical settings. They also believed that practices have to ﬁt with
organizational values and with local circumstances. Further, they
understood that as a government funded agency, VHA must
respond to political pressures. These include addressing the needs
of elected ofﬁcials and the groups that lobby those ofﬁcials.
Finally and most importantly, they believed it is important to
attempt to meet compelling patient needs. They were most con-
cerned about conditions that affect large numbers of individuals or
affect high-risk populations. When there was no clear evidence
regarding how to address those needs, they believed health care
organizations must turn to the art of medicine by using the collec-
tive wisdom of the ﬁeld in the form of consensus-based best
practices.
What these policymakers seemed to imply is that just as it would
be foolish to ignore research evidence when adopting clinical
policies, it would be equally foolish to ignore practical concerns,
values and the needs of health care consumers. For serious condi-
tions that have no clear EBP, practitioners must alleviate suffering
by using the art of medicine in the form of best practices. Further,
if individuals do not seem to respond to the usual treatment, then
clinicians must try something else. And even when following the
evidence, we must realize that we are always reﬁning what we
know.The best practice is an ever-evolving one that makes the best
use of science and art to provide the best care possible to many
varied individuals. It is also one that makes reasoned and critical
use of all the available information. Lewis may have put it best
when he wrote:
Where knowledge is deﬁnitive, rely on the algorithm; where
knowledge is provisional and incomplete, redouble the scien-
tiﬁc effort; where uncertainty looms large, engage the right
side of the brain (p. 171) [7].
All of this implies that those concerned with building the evi-
dence base and those concerned with delivering patient care must
work in concert, designing interventions that are broadly appli-
cable to actual clinical practice [32–34]. Research and practice,
however, are strange bedfellows. Whereas research is a slow and
deliberate process, the need to improve clinical care is often time-
sensitive. Additionally, researchers have career demands (e.g. the
need to develop a coherent research programme and become an
expert in a particular area) that may not necessarily follow public
health needs. Ultimately, however, the quality of health care
depends on ﬁnding a way to blend medical art and science.
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